A Multiparametric in vitro Strategy for Small Molecule Drug-Induced Liver Injury Risk Mitigation in Early Drug Development

Clicks: 2
ID: 331544
2026
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #143 of 144 articles by views in toxicological sciences : an official journal of the society of toxicology

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 144 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Drug-induced liver injury (DILI) remains a major cause of preclinical and clinical attrition, reflecting persistent gaps in the predictive translation of preclinical safety data to human outcomes. To address these gaps, we established a refined multiparametric framework for early DILI risk prediction using a balanced reference set of 170 drugs with established clinical outcomes. Thirty physicochemical, mechanistic endpoints and exposure-related features were systematically evaluated to identify high-specificity predictors of intrinsic DILI risk. Cytotoxicity in primary human hepatocytes and human liver microtissues, mitochondrial toxicity (i.e., mitotoxicity) and bile salt export pump inhibition were identified as top predictive features. Incorporation of clinical exposure data to derive margins of safety substantially improved assay performance, emphasizing the importance of exposure normalization. A multiparametric, flag-based hazard framework integrating ≥ 2 hazard flags achieved 98% specificity and a positive likelihood ratio of 18, providing a pragmatic approach for early compound triage and confidence in early decision making. Random Forest models further enhanced predictive performance, identifying exposure, predicted lipophilicity (e.g., cLogD), mitotoxicity, cytotoxicity and hepatic clearance as major contributors to DILI risk, with exposure-informed models achieving a balanced accuracy of 0.72. Application of the framework to contemporary Genentech portfolio molecules demonstrated translational utility in refining risk categorization and distinguishing between borderline or 0-1 flag compounds. Collectively, this work establishes a mechanistically informed and machine learning-enabled platform that combines interpretability, specificity and practicality to guide safer molecule design in drug discovery and reduce hepatotoxicity-related attrition in clinical development.
Reference Key
openalex_W7220465212 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Leah M. Norona, Fjodor Melnikov, Tomomi Kiyota, Christopher Lawson, Cyrus Khojasteh, Joyce Liu, Kevin M. Johnson, Tony Pourmohamad, Lennart T. Anger, William R. Proctor, Aaron M. Fullerton
Journal toxicological sciences : an official journal of the society of toxicology
Year 2026
DOI
10.1093/toxsci/kfag124
URL
https://doi.org/10.1093/toxsci/kfag124
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.